Women’s Care Florida among first 100 DYSIS users in USA – DYSIS Medical

Women’s Care Florida among first 100 DYSIS users in USA

Women’s Care Florida among first 100 DYSIS users in USA

Women’s Care Florida among first 100 U.S. OB-GYN practices implementing advanced cervical imaging technology

First locations in Tampa Bay to standardize colposcopy after abnormal Pap smears  


Edinburgh, UK, September 26, 2016 – DYSIS Medical Ltd. (DYSIS), an innovative women’s health company, announced today that Women’s Care Florida has implemented the DYSIS Advanced Cervical Imaging System for early detection of cervical cancer.

Women’s Care Florida, one of the largest OB-GYN groups in Florida, added the DYSIS advanced digital colposcope to two of their locations in Brandon and Tampa, making them one of the first 100 practices to adopt this technology in the United States.

“Women’s Care Florida decided to implement DYSIS because this is cutting-edge, state-of-the-art colposcopic technology,” said Dr. Martha E. Kapitz, a Women’s Care Florida physician.

Colposcopy, which can be subjective and has remained unchanged for decades, is an exam performed after a woman has an abnormal Pap smear.  DYSIS has advanced the standard colposcopy technique by using computer-aided mapping.

“With the DYSIS technology, it improves detection by actually mapping out areas of the cervix that look most suspicious,” explained Dr. Kapitz.  DYSIS quantifies colposcopy by capturing images and creating a color-coded map, highlighting the more intense acetowhitened areas. Physicians can then use a guided biopsy procedure to assist in identifying the best areas to biopsy.

DYSIS further helps practices like Women’s Care Florida with standardizing the subjective colposcopy procedure, which is important to physicians in terms of improving outcomes and providing the best care to their patients.

“Cervical detection is something that we have already been doing, but now we’re just bringing it up to the next level to improve detection for our patients and improve overall care of women,” said Dr. Kapitz.

“We are excited to be working with Women’s Care Florida, a well-renowned OB-GYN physician group in Florida that recognizes the importance of advancing today’s cervical screening technology. By standardizing the currently subjective colposcopy procedure, we can help improve care for women,” said Kim Stebbings, US President of DYSIS Medical.

About Women’s Care Florida

Women’s Care Florida, LLC (WCF) is a multi-specialty, women’s health, physician group offering patient care services in obstetrics, gynecology, gynecologic oncology, urogynecology, gynecologic and breast pathology, breast surgery and maternal-fetal medicine. The group has over 200 providers in over 60 outpatient locations, including a women’s services laboratory and a breast center.


About DYSIS Medical

DYSIS Medical has its global headquarters in Edinburgh and US Headquarters in Tampa, FL. The company is committed to saving lives through the early detection and diagnosis of disease using biophotonic innovations. It aims to be the global leader in automated optical molecular imaging technologies for medical diagnostic and screening applications. For more information, please visit: www.abnormalpapsmear.com or call 844-DYSISMED.

About the DYSIS colposcope

The DYSIS colposcope differs from traditional colposcopes by measuring the cervical epithelium automatically using Dynamic Spectral Imaging and producing a map of the cervix, which assists the clinician with assessing the cervix, identifying biopsy locations and performing treatment if needed.

About cervical cancer

Each year, more than 12,000 women are diagnosed in the US with cervical cancer and over 4,000 will die.  Worldwide, cervical cancer is the fourth most common cancer for women and the seventh most common cancer overall. While it is the only entirely preventable cancer, approximately half a million women are diagnosed with the disease every year.